Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments
ABSTRACT Objective: To examine the relationship between adoption of direct oral anticoagulants (DOACs) and health and cost outcomes for patients with nonvalvular atrial fibrillation. Study Design: Real-world cohort study. Methods: US adults who newly initiated treatment for nonvalvular atrial fibrillation […]
Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments Read More »